97326-40-4

Upstream product

• 70978-37-9 1-(azidomethyl)-4-methoxybenzene 
• 75020-41-6 5-Hydroxy-1-<(4-methoxyphenyl)methyl>-1H-1,2,3-triazole-4-carboxylic Acid Ethyl Ester 

Downstream Products

• 106157-60-2 3-(4-Methoxy-benzyl)-10-(4-methyl-piperazin-1-yl)-3H-4-oxa-1,2,3,9-tetraaza-benzo[f]azulene 
• 106157-40-8 5-Chloro-1-(4-methoxy-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid (2-hydroxy-phenyl)-amide 
• 106157-45-3 3-<(4-Methoxyphenyl)methyl>-3H-1,2,3-triazolo<4,5-b><1,5>benzoxazepin-10(9H)-one 
• 96938-91-9 5-Chloro-1-<(4-methoxyphenyl)methyl>-1H-1,2,3-triazole-4-carbonyl chloride 

Relevant academic research and scientific papers

AhR MODULATORS

Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae: (I) wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2c and R2d have the meanings provided in the specification.

Heterocyclic Studies. 2 . 5-Chloro-1H-1,2,3-triazole-4-carboxaldehydes, Preparation and Rearrangement Reactions

A general procedure for synthesis of 5-chloro-1H-1,2,3-triazole-4-carboxaldehydes 4 and the rearrangement reaction of 4-(N-substituted)iminomethylene-1H-1,2,3-triazol-5-ols 6 into N-substituted-1H-1,2,3-triazole-4-carboxamides 7 are described.